Discover the potential of ABCL AbCellera, a biotech unicorn in AI drug discovery. While investing in ABCL may yield significant returns, risks are also involved. Kris offers insights into ABCL's earnings, but predicting a 10X return or a 100% loss is speculative. Consider ABCL as a potential bargain, but research thoroughly before investing.